Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911724
Status:
COMPLETED
Last Update Posted:
2023-09-07
First Post:
2023-06-10
Brief Title:
Association Between Inflammatory Biomarkers and LV Function in Patients With CVD
Sponsor:
Damanhour University
Organization:
Damanhour University
Study Overview
Official Title:
Prognostic Significance of Inflammatory Biomarkers and LV Functionin Patients With Coronary Heart Disease and Heart Failure
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The association of novel inflammatory biomarkers with cardiovascular diseases is still obscure The present study aimed to investigate the relationship of various inflammatory biomarkers with the existence as well as the extent of heart failure HF and coronary artery disease CAD suggesting a link between inflammation and cardiovascular diseases and all-cause 30- and -90 day of hospital readmission Methods We enrolled a total of 120 patients with HF asymptomatic CAD and 60 healthy controls HC without cardiovascular diseases
Detailed Description:
The present study aimed to investigate the relationship of various inflammatory biomarkers with the existence as well as the extent of heart failure HF and coronary artery disease CAD suggesting a link between inflammation and cardiovascular diseases and all-cause 30- and -90 day of hospital readmission
We enrolled a total of 60 patients with HF 60 asymptomatic CAD patients and 60 healthy controls HC without cardiovascular diseases
Group I 60 Healthy Subjects Group II 60 Patients with Stable Angina asymptomatic CAD Group III 60 Patients with Heart Failure
Clinical parameters glycemic and lipid profile vaspin visfatin high-sensitivity C-reactive protein sortilin homocysteine troponin I fetuin A and lipoprotein A levels were assayed
Patients will be followed up to assess all-cause 30- and -90 day of hospital readmission
We enrolled a total of 60 patients with HF 60 asymptomatic CAD patients and 60 healthy controls HC without cardiovascular diseases
Group I 60 Healthy Subjects Group II 60 Patients with Stable Angina asymptomatic CAD Group III 60 Patients with Heart Failure
Clinical parameters glycemic and lipid profile vaspin visfatin high-sensitivity C-reactive protein sortilin homocysteine troponin I fetuin A and lipoprotein A levels were assayed
Patients will be followed up to assess all-cause 30- and -90 day of hospital readmission
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None